194 related articles for article (PubMed ID: 6487362)
1. Comparison of high affinity binding of calcium channel blocking drugs to vascular smooth muscle and cardiac sarcolemmal membranes.
Sarmiento JG; Janis RA; Katz AM; Triggle DJ
Biochem Pharmacol; 1984 Oct; 33(20):3119-23. PubMed ID: 6487362
[TBL] [Abstract][Full Text] [Related]
2. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.
Williams LT; Tremble P
J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938
[TBL] [Abstract][Full Text] [Related]
3. Binding of the calcium channel blocker nitrendipine to its receptor in purified sarcolemma from canine cardiac ventricle.
Sarmiento JG; Janis RA; Colvin RA; Triggle DJ; Katz AM
J Mol Cell Cardiol; 1983 Feb; 15(2):135-7. PubMed ID: 6304327
[TBL] [Abstract][Full Text] [Related]
4. Identification of calcium antagonist receptor binding sites using (3H)nitrendipine in bovine tracheal smooth muscle membranes.
Cheng JB; Bewtra A; Townley RG
Experientia; 1984 Mar; 40(3):267-9. PubMed ID: 6321228
[TBL] [Abstract][Full Text] [Related]
5. Calcium-channel antagonist binding to isolated vascular smooth muscle membranes.
Triggle CR; Agrawal DK; Bolger GT; Daniel EE; Kwan CY; Luchowski EM; Triggle DJ
Can J Physiol Pharmacol; 1982 Dec; 60(12):1738-41. PubMed ID: 7165866
[TBL] [Abstract][Full Text] [Related]
6. Identification of two calcium channel receptor sites for [3H]nitrendipine in mammalian cardiac and smooth muscle membrane.
Rogart RB; deBruyn Kops A; Dzau VJ
Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7452-6. PubMed ID: 2429306
[TBL] [Abstract][Full Text] [Related]
7. Nitrendipine: effects on vascular responses and myocardial binding.
McBride W; Mukherjee A; Haghani Z; Wheeler-Clark E; Brady J; Gandler T; Bush L; Buja LM; Willerson JT
Am J Physiol; 1984 Nov; 247(5 Pt 2):H775-83. PubMed ID: 6093595
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
Janis RA; Sarmiento JG; Maurer SC; Bolger GT; Triggle DJ
J Pharmacol Exp Ther; 1984 Oct; 231(1):8-15. PubMed ID: 6208356
[TBL] [Abstract][Full Text] [Related]
9. Effects of Bay k 8644, a dihydropyridine analog, on [3H]nitrendipine binding to canine cardiac sarcolemma and the relationship to a positive inotropic effect.
Vaghy PL; Grupp IL; Grupp G; Schwartz A
Circ Res; 1984 Oct; 55(4):549-53. PubMed ID: 6206963
[TBL] [Abstract][Full Text] [Related]
10. Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
Gould RJ; Murphy KM; Snyder SH
Mol Pharmacol; 1984 Mar; 25(2):235-41. PubMed ID: 6422256
[TBL] [Abstract][Full Text] [Related]
11. Binding of [3H]nimodipine to cardiac and smooth muscle membranes.
Janis RA; Maurer SC; Sarmiento JG; Bolger GT; Triggle DJ
Eur J Pharmacol; 1982 Aug; 82(3-4):191-4. PubMed ID: 7128686
[TBL] [Abstract][Full Text] [Related]
12. Binding of the new calcium entry blocker nilvadipine to rat aortic and guinea pig left ventricular membranes.
Matsuo M; Koibuchi Y; Tomoi M; Ono T; Shibayama F; Ohtsuka M
Arzneimittelforschung; 1989 May; 39(5):576-9. PubMed ID: 2757673
[TBL] [Abstract][Full Text] [Related]
13. Interference of sodium with [3H]-nitrendipine binding to cardiac membranes.
Schwartz J; Velly J
Br J Pharmacol; 1985 Feb; 84(2):511-5. PubMed ID: 3156649
[TBL] [Abstract][Full Text] [Related]
14. Volatile anesthetics depress calcium channel blocker binding to bovine cardiac sarcolemma.
Drenger B; Quigg M; Blanck TJ
Anesthesiology; 1991 Jan; 74(1):155-65. PubMed ID: 1986641
[TBL] [Abstract][Full Text] [Related]
15. Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.
Garcia ML; King VF; Siegl PK; Reuben JP; Kaczorowski GJ
J Biol Chem; 1986 Jun; 261(18):8146-57. PubMed ID: 2424894
[TBL] [Abstract][Full Text] [Related]
16. Direct photoaffinity labeling of the high affinity nitrendipine-binding site in subcellular membrane fractions isolated from canine myocardium.
Campbell KP; Lipshutz GM; Denney GH
J Biol Chem; 1984 May; 259(9):5384-7. PubMed ID: 6325434
[TBL] [Abstract][Full Text] [Related]
17. Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites.
Bristow MR; Ginsburg R; Laser JA; McAuley BJ; Minobe W
Br J Pharmacol; 1984 Jun; 82(2):309-20. PubMed ID: 6329392
[TBL] [Abstract][Full Text] [Related]
18. Correlation of nitrendipine and Bay k 8644 binding to isolated canine heart sarcolemma with their pharmacological effects on the canine heart.
Vaghy PL; Grupp IL; Grupp G; Balwierczak JL; Williams JS; Schwartz A
Eur J Pharmacol; 1984 Jul; 102(2):373-4. PubMed ID: 6207033
[No Abstract] [Full Text] [Related]
19. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
[TBL] [Abstract][Full Text] [Related]
20. Comparison of [3H]nitrendipine binding to heart membranes of normotensive and spontaneously hypertensive rats.
Chatelain P; Demol D; Roba J
J Cardiovasc Pharmacol; 1984; 6(2):220-3. PubMed ID: 6200707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
